|
Mechanismμ opioid receptor partial agonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismσ2 receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Application |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismσ1 receptor agonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Advantx Pharmaceuticals
0 Patents (Medical) associated with Advantx Pharmaceuticals
100 Deals associated with Advantx Pharmaceuticals
100 Translational Medicine associated with Advantx Pharmaceuticals